Medtech Exports Rise by Another 5.9% Until June, Reaching 1.1 Billion

Spanish medtech increases its weight abroad in the first half of the year. Exports of technology and medical equipment closed the period from January to June with a value of 1,1 billion euros, which represents an increase of 5.9% compared to the previous year and a new historical record in the period. With this, there are already four consecutive increases during the first half of the year in Spain’s medtech exports, after increases of 15.8% in 2021, 10.5% in 2022 and 4.6% in 2023.

According to data from Icex Spain Export and Investment, the cumulative increase since 2019, before the outbreak of the pandemic, stands at 41%, while ten years from now, compared to 2012, it stands at 87%.

Medical and surgical instruments, with exports in the first half of the year worth 354 million euros; consumables, with 297 million; and orthopaedic products, with 295 million, were the main export categories of technology and medical equipment. Next in line were electromedical articles, with 119 million euros, and medical furniture, with 42.8 million.

In terms of markets, Portugal is in a prominent first position among the main destinations for medtech exports, with a value of 229 million euros in the first half of the year and an above-average increase of 9.5%, compared to the period from January to June 2023.

Over the past ten years, the medtech exports have almost doubled, with an increase of 87%.

Second place goes to France: sales of healthcare technology and equipment to the French market rose by 4.6% in the first half of the year to 124 million euros. Italy took the bronze on the podium of the sector’s customers, with 108 million euros and a year-on-year increase of 6.3%.

Among the twenty most important markets for the medtech sector, exports of technology and healthcare equipment only fell until June in Belgium, with a drop of 53%, to 29.8 million euros, and in Mexico , with a contraction of 18%, to 8.9 million.

However, medtech exports in markets such as Malaysia and Ireland soared , albeit with moderate absolute figures. In the Asian country, the increase was 231.8%, to a value of 9.9 million euros, and in the European market the rise was 168%, to 18.4 million.

The rises were also significant in the Netherlands, Italy, the United Kingdom and Poland, all of which are in the top 10 clients in the sector. In the Netherlands, the rise was 18.8%, up to 74 million euros; in Italy, 27%, up to 61 million; in the United Kingdom, 19%, up to 34 million, and in Poland, 16%, up to 25 million euros.

__

(Featured image by CDC via Unsplash)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in PlantaDoce. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us